Breast Cancer Management

Breast Cancer Manag

1758-1923

1758-1931

Therapeutic Area

Diagnostic Imaging, Genomics, Oncology, Patient Safety, Pharmacoeconomics, Pharmacogenetics & Pharmacogenomics, Psychology, Surgery, Women's Health

Breast Surgeons, Clinicians, Nurse Oncologists, Nurse Practitioners, Nurse Practitioners/Physician Assistants, Oncologists, Patients, Pharmacologists, Physician Assistants, Physicians, Physicians - Medicine, Primary Care Physicians, Radiation Oncologists, Residents, Surgical Oncologists

Screening programs, better treatments and a general increase in awareness have resulted in declining death rates from breast cancer over the past two decades. However, in developed countries, the disease remains the second leading cause of cancer death in women after lung cancer. The chance of developing invasive breast cancer at some time in a woman’s life is approximately 1 in 8, and the chance that breast cancer will be responsible for a woman’s death is about 1 in 35. Effective management of this relatively common disease can therefore have a significant impact on survival at the population level, and have a profound effect on lives of those directly affected by the disease and their loved ones. Breast Cancer Management (ISSN: 1758-1923) addresses key issues in disease management by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal also highlights significant advances in basic and translational research, and places them in context for future therapy. Breast Cancer Management provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease. Recent research findings and advances clinical practice in the field are reported and analyzed by international experts. The journal presents this information in clear, accessible formats. All articles are subject to independent review by a minimum of two independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal’s Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3. Coverage includes: Diagnosis and imaging, Surgical approaches, Radiotherapy, Systemic therapies, Cancer clinical trials, Genetic aspects of disease, Personalized medicine, Translational research and biomarker studies, Management of psychological distress, Epidemiological studies, Pharmacoeconomics, Evidence-based treatment guidelines.

No associations affiliated with this journal

Future Medicine Ltd.

Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines